Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Beam Therapeutics Inc Logo

ARKG Holdings of Beam Therapeutics (BEAM) - Updated Daily

Maxinomics.com icon
YouTube Logo
Date
Direction
Shares
Fund Weight
Fund
September 16, 2022
BUY20.578k0.0419%ARKG
September 14, 2022
BUY5.621k0.0112%ARKG
September 13, 2022
BUY82.577k0.1545%ARKG
April 14, 2022
BUY13.409k0.0193%ARKG
April 13, 2022
BUY2.574k0.0038%ARKG

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$46.82
⚖️Weighting🧢Market Cap
4.02%$3.30b
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
535.88
🏋️‍♀️Weight Rank Across All Funds🌏Country
13🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$80.152.76%
Description
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that enables precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Website
beamtx.com

Research Notes and Commentary for BEAM